Furthermore, Wang et al. performed anti-CD30 CAR-T cell therapy on 11 patients with r/r HL, infusing 1.5 × 107 CAR-T cells per kg of weight. The gene discussed is TNFRSF8; the disease is Hodgkins lymphoma.